{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:19:33Z","timestamp":1791523173793,"version":"4.3.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,1,9]],"date-time":"2008-01-09T00:00:00Z","timestamp":1199836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1038\/sj.npp.1301643","type":"journal-article","created":{"date-parts":[[2008,1,9]],"date-time":"2008-01-09T15:37:15Z","timestamp":1199893035000},"page":"2505-2516","source":"Crossref","is-referenced-by-count":232,"title":["Blunted Psychotomimetic and Amnestic Effects of \u0394-9-Tetrahydrocannabinol in Frequent Users of Cannabis"],"prefix":"10.1038","volume":"33","author":[{"given":"Deepak Cyril","family":"D'Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Braley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralitza","family":"Gueorguieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Zimolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Krystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,9]]},"reference":[{"key":"BF1301643_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0091-3057(93)90546-6","volume":"46","author":"ME Abood","year":"1993","unstructured":"Abood ME, Sauss C, Fan F, Tilton CL, Martin BR (1993). Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Pharmacol Biochem Behav 46: 575\u2013579.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301643_CR2","first-page":"241","volume":"92","author":"JC Anthony","year":"1989","unstructured":"Anthony JC, Trinkoff AM (1989). United States epidemiologic data on drug use and abuse: how are they relevant to testing abuse liability of drugs? NIDA Res Monogr 92: 241\u2013266.","journal-title":"NIDA Res Monogr"},{"key":"BF1301643_CR3","first-page":"825","volume":"23","author":"LM Bornheim","year":"1995","unstructured":"Bornheim LM, Kim KY, Li J, Perotti BY, Benet LZ (1995). Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain. Drug Metab Dispos 23: 825\u2013831.","journal-title":"Drug Metab Dispos"},{"key":"BF1301643_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/13854049108403297","volume":"5","author":"J Brandt","year":"1991","unstructured":"Brandt J (1991). \u2018The hopkins verbal learning test. Development of a new memory test with 6 equivalent forms\u2019. Clin Neuropsychol 5: 125\u2013142.","journal-title":"Clin Neuropsychol"},{"key":"BF1301643_CR5","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1046\/j.1471-4159.1999.0732447.x","volume":"73","author":"CS Breivogel","year":"1999","unstructured":"Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Vogt LJ, Sim-Selley LJ (1999). Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 73: 2447\u20132459.","journal-title":"J Neurochem"},{"key":"BF1301643_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1024465317902","volume":"11","author":"JD Bremner","year":"1998","unstructured":"Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS et al (1998). Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress 11: 125\u2013136.","journal-title":"J Trauma Stress"},{"key":"BF1301643_CR7","volume-title":"Nonparametric Analysis of Longitudinal Data in Factorial Experiments","author":"E Brunner","year":"2002","unstructured":"Brunner E, Domhof S, Langer F (2002). Nonparametric Analysis of Longitudinal Data in Factorial Experiments. John Wiley and Sons: New York, NY."},{"key":"BF1301643_CR8","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1176\/appi.ajp.161.11.1967","volume":"161","author":"AJ Budney","year":"2004","unstructured":"Budney AJ, Hughes JR, Moore BA, Vandrey R (2004). Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 161: 1967\u20131977.","journal-title":"Am J Psychiatry"},{"key":"BF1301643_CR9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/0028-3932(91)90035-7","volume":"29","author":"FW Bylsma","year":"1991","unstructured":"Bylsma FW, Rebok GW, Brandt J (1991). Long-term retention of implicit learning in Huntington's disease. Neuropsychologia 29: 1213\u20131221.","journal-title":"Neuropsychologia"},{"key":"BF1301643_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","volume":"57","author":"A Caspi","year":"2005","unstructured":"Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H et al (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57: 1117\u20131127.","journal-title":"Biol Psychiatry"},{"key":"BF1301643_CR11","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.291.17.2114","volume":"291","author":"WM Compton","year":"2004","unstructured":"Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS (2004). Prevalence of marijuana use disorders in the United States: 1991\u20131992 and 2001\u20132002. JAMA 291: 2114\u20132121.","journal-title":"JAMA"},{"key":"BF1301643_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s002130100741","volume":"157","author":"PJ Conrod","year":"2001","unstructured":"Conrod PJ, Peterson JB, Pihl RO (2001). Reliability and validity of alcohol-induced heart rate increase as a measure of sensitivity to the stimulant properties of alcohol. Psychopharmacology (Berl) 157: 20\u201330.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1301643_CR13","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0006-2952(98)00185-3","volume":"56","author":"R de Miguel","year":"1998","unstructured":"de Miguel R, Romero J, Munoz RM, Garcia-Gil L, Gonzalez S, Villanua MA et al (1998a). Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs. Biochem Pharmacol 56: 1331\u20131338.","journal-title":"Biochem Pharmacol"},{"key":"BF1301643_CR14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0006-2952(98)00185-3","volume":"56","author":"R de Miguel","year":"1998","unstructured":"de Miguel R, Romero J, Munoz RM, Garcia-Gil L, Gonzalez S, Villanua MA et al (1998b). Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs. Biochem Pharmacol 56: 1331\u20131338.","journal-title":"Biochem Pharmacol"},{"key":"BF1301643_CR15","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1046\/j.1471-4159.2000.0741627.x","volume":"74","author":"V Di Marzo","year":"2000","unstructured":"Di Marzo V, Berrendero F, Bisogno T, Gonzalez S, Cavaliere P, Romero J et al (2000). Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. J Neurochem 74: 1627\u20131635.","journal-title":"J Neurochem"},{"key":"BF1301643_CR16","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","volume":"29","author":"DC D'Souza","year":"2004","unstructured":"D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT et al (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558\u20131572.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301643_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0074-7742(06)78010-2","volume":"78","author":"DC D'Souza","year":"2007","unstructured":"D'Souza DC (2007). Cannabinoids and psychosis. Int Rev Neurobiol 78: 289\u2013326.","journal-title":"Int Rev Neurobiol"},{"issue":"Suppl 1","key":"BF1301643_CR18","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0376-8716(99)00164-7","volume":"59","author":"T Eissenberg","year":"2000","unstructured":"Eissenberg T, Balster RL (2000). Initial tobacco use episodes in children and adolescents: current knowledge, future directions. Drug Alcohol Depend 59 (Suppl 1): S41\u2013S60.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301643_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1017\/S0033291702006402","volume":"33","author":"DM Fergusson","year":"2003","unstructured":"Fergusson DM, Horwood LJ, Swain-Campbell NR (2003b). Cannabis dependence and psychotic symptoms in young people. Psychol Med 33: 15\u201321.","journal-title":"Psychol Med"},{"key":"BF1301643_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/archpsyc.60.10.1033","volume":"60","author":"DM Fergusson","year":"2003","unstructured":"Fergusson DM, Horwood LJ, Lynskey MT, Madden PA (2003a). Early reactions to cannabis predict later dependence. Arch Gen Psychiatry 60: 1033\u20131039.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1301643_CR21","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders","author":"MB First","year":"2002","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders Non-patient edition. In: American Psychiatric Association, Washington, DC."},{"key":"BF1301643_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000054468","volume":"70","author":"S Gonzalez","year":"1999","unstructured":"Gonzalez S, Manzanares J, Berrendero F, Wenger T, Corchero J, Bisogno T et al (1999). Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland. Neuroendocrinology 70: 137\u2013145.","journal-title":"Neuroendocrinology"},{"key":"BF1301643_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.pbb.2005.01.028","volume":"81","author":"S Gonzalez","year":"2005","unstructured":"Gonzalez S, Cebeira M, Fernandez-Ruiz J (2005). Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav 81: 300\u2013318.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301643_CR24","first-page":"288","volume":"22","author":"M Gordon","year":"1986","unstructured":"Gordon M (1986). Microprocessor-based assessment of attention deficit disorders (ADD). Psychopharmacol Bull 22: 288\u2013290.","journal-title":"Psychopharmacol Bull"},{"key":"BF1301643_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/09595230310001613976","volume":"22","author":"B Green","year":"2003","unstructured":"Green B, Kavanagh D, Young R (2003). Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 22: 453\u2013460.","journal-title":"Drug Alcohol Rev"},{"key":"BF1301643_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0306-3623(94)90027-2","volume":"25","author":"FS Guimaraes","year":"1994","unstructured":"Guimaraes FS, de Aguiar JC, Mechoulam R, Breuer A (1994). Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze. Gen Pharmacol 25: 161\u2013164.","journal-title":"Gen Pharmacol"},{"key":"BF1301643_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00005053-196509000-00006","volume":"141","author":"CA Haertzen","year":"1965","unstructured":"Haertzen CA (1965). Addiction Research Center Inventory (ARCI): development of a general drug estimation scale. J Nerv Ment Dis 141: 300\u2013307.","journal-title":"J Nerv Ment Dis"},{"key":"BF1301643_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2466\/pr0.1966.18.1.163","volume":"18","author":"CA Haertzen","year":"1966","unstructured":"Haertzen CA (1966). Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI). Psychol Rep 18: 163\u2013194.","journal-title":"Psychol Rep"},{"key":"BF1301643_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/09595230412331324554","volume":"23","author":"W Hall","year":"2004","unstructured":"Hall W, Degenhardt L, Teesson M (2004). Cannabis use and psychotic disorders: an update. Drug Alcohol Rev 23: 433\u2013443.","journal-title":"Drug Alcohol Rev"},{"key":"BF1301643_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/hipo.10081","volume":"13","author":"RE Hampson","year":"2003","unstructured":"Hampson RE, Simeral JD, Kelly EJ, Deadwyler SA (2003). Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons. Hippocampus 13: 543\u2013556.","journal-title":"Hippocampus"},{"key":"BF1301643_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s002130050848","volume":"141","author":"M Haney","year":"1999","unstructured":"Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW (1999a). Abstinence symptoms following oral THC administration to humans. Psychopharmacology 141: 385\u2013394.","journal-title":"Psychopharmacology"},{"key":"BF1301643_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s002130050849","volume":"141","author":"M Haney","year":"1999","unstructured":"Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW (1999b). Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) 141: 395\u2013404.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1301643_CR33","first-page":"45","volume-title":"NIDA Research Monograph Series","author":"J Harclerode","year":"1984","unstructured":"Harclerode J (1984). Endocrine effects of marijuana in the male: preclinical studies. In: Braude MC and Ludford JP (eds). NIDA Research Monograph Series. National Institute on Drug Abuse: Rockville, MD, pp 45\u2013114."},{"key":"BF1301643_CR34","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1038\/sj.npp.1301197","volume":"31","author":"C Henquet","year":"2006","unstructured":"Henquet C, Rosa A, Krabbendam L, Papiol S, Fananas L, Drukker M et al (2006a). An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 31: 2748\u20132757.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301643_CR35","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1038\/sj.npp.1301197","volume":"31","author":"C Henquet","year":"2006","unstructured":"Henquet C, Rosa A, Krabbendam L, Papiol S, Fanan\u00e1s L, Drukker M et al (2006b). An experimental study of catechol-O-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 31: 2748\u20132757.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301643_CR36","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/schbul\/sbi027","volume":"31","author":"C Henquet","year":"2005","unstructured":"Henquet C, Murray R, Linszen D, van Os J (2005). The environment and schizophrenia: the role of cannabis use. Schizophr Bull 31: 608\u2013612.","journal-title":"Schizophr Bull"},{"key":"BF1301643_CR37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-0447.1988.tb08576.x","volume":"345","author":"LE Hollister","year":"1988","unstructured":"Hollister LE (1988). Cannabis--1988. Acta Psychiatr Scand Suppl 345: 108\u2013118.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"BF1301643_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2006.11.015","volume":"89","author":"CJ Hopfer","year":"2007","unstructured":"Hopfer CJ, Lessem JM, Hartman CA, Stallings MC, Cherny SS, Corley RP et al (2007). A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. Drug Alcohol Depend 89: 34\u201341.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301643_CR39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ajmg.b.30378","volume":"141","author":"CJ Hopfer","year":"2006","unstructured":"Hopfer CJ, Young SE, Purcell S, Crowley TJ, Stallings MC, Corley RP et al (2006). Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Am J Med Genet B Neuropsychiatr Genet 141: 895\u2013901.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BF1301643_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1749-6632.1976.tb49901.x","volume":"282","author":"RT Jones","year":"1976","unstructured":"Jones RT, Benowitz N, Bachman J (1976). Clinical studies of cannabis tolerance and dependence. Ann N Y Acad Sci 282: 221\u2013239.","journal-title":"Ann N Y Acad Sci"},{"key":"BF1301643_CR41","doi-asserted-by":"publisher","first-page":"143S","DOI":"10.1002\/j.1552-4604.1981.tb02589.x","volume":"21","author":"RT Jones","year":"1981","unstructured":"Jones RT, Benowitz NL, Herning RI (1981). Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21: 143S\u2013152S.","journal-title":"J Clin Pharmacol"},{"key":"BF1301643_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.15288\/jsa.2000.61.367","volume":"61","author":"DB Kandel","year":"2000","unstructured":"Kandel DB, Chen K (2000). Types of marijuana users by longitudinal course. J Stud Alcohol 61: 367\u2013378.","journal-title":"J Stud Alcohol"},{"key":"BF1301643_CR43","doi-asserted-by":"crossref","unstructured":"Kay SR, Opler LA, Lindenmayer JP (1989). The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry-Suppl 59\u201367.","DOI":"10.1192\/S0007125000291514"},{"key":"BF1301643_CR44","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.addbeh.2004.03.039","volume":"29","author":"LM Kelleher","year":"2004","unstructured":"Kelleher LM, Stough C, Sergejew AA, Rolfe T (2004). The effects of cannabis on information-processing speed. Addict Behav 29: 1213\u20131219.","journal-title":"Addict Behav"},{"key":"BF1301643_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","volume":"94","author":"FM Leweke","year":"2007","unstructured":"Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Kranaster L et al (2007). Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophr Res 94: 29\u201336.","journal-title":"Schizophr Res"},{"key":"BF1301643_CR46","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2165\/00023210-200418130-00005","volume":"18","author":"FM Leweke","year":"2004","unstructured":"Leweke FM, Gerth CW, Klosterkotter J (2004). Cannabis-associated psychosis: current status of research. CNS Drugs 18: 895\u2013910.","journal-title":"CNS Drugs"},{"key":"BF1301643_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0091-3057(00)00201-X","volume":"66","author":"FM Leweke","year":"2000","unstructured":"Leweke FM, Schneider U, Radwan M, Schmidt E, Emrich HM (2000). Different effects of nabilone and cannabidiol on binocular depth inversion in Man. Pharmacol Biochem Behav 66: 175\u2013181.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301643_CR48","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002130050884","volume":"142","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Schneider U, Thies M, Munte TF, Emrich HM (1999). Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology (Berl) 142: 230\u2013235.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1301643_CR49","volume-title":"2nd International Cannabis and Mental Health Conference","author":"FM Leweke","year":"2007","unstructured":"Leweke FM (2007). Cannabidiol as an antipsychotic\u2014new perspectives. In: 2nd International Cannabis and Mental Health Conference. Institute of Psychiatry: London, UK."},{"key":"BF1301643_CR50","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/3-540-26573-2_24","volume":"168","author":"AH Lichtman","year":"2005","unstructured":"Lichtman AH, Martin BR (2005). Cannabinoid tolerance and dependence. Handb Exp Pharmacol 168: 691\u2013717. Review.","journal-title":"Handb Exp Pharmacol"},{"key":"BF1301643_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1054\/plef.2001.0351","volume":"66","author":"AH Lichtman","year":"2002","unstructured":"Lichtman AH, Varvel SA, Martin BR (2002). Endocannabinoids in cognition and dependence. Prostaglandins Leukot Essent Fatty Acids 66: 269\u2013285.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"BF1301643_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1360-0443.1997.tb03372.x","volume":"92","author":"MJ Lyons","year":"1997","unstructured":"Lyons MJ, Toomey R, Meyer JM, Green AI, Eisen SA, Goldberg J et al (1997). How do genes influence marijuana use? The role of subjective effects. Addiction 92: 409\u2013417.","journal-title":"Addiction"},{"key":"BF1301643_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.tips.2004.04.005","volume":"25","author":"BR Martin","year":"2004","unstructured":"Martin BR, Sim-Selley LJ, Selley DE (2004). Signaling pathways involved in the development of cannabinoid tolerance. Trends Pharmacol Sci 25: 325\u2013330.","journal-title":"Trends Pharmacol Sci"},{"key":"BF1301643_CR54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1039\/a703973e","volume":"16","author":"R Mechoulam","year":"1999","unstructured":"Mechoulam R, Ben-Shabat S (1999). From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis. Nat Prod Rep 16: 131\u2013143.","journal-title":"Nat Prod Rep"},{"key":"BF1301643_CR55","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1006\/nbdi.1998.0224","volume":"5","author":"LL Murphy","year":"1998","unstructured":"Murphy LL, Munoz RM, Adrian BA, Villanua MA (1998a). Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol Dis 5: 432\u2013446.","journal-title":"Neurobiol Dis"},{"key":"BF1301643_CR56","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1006\/nbdi.1998.0224","volume":"5","author":"LL Murphy","year":"1998","unstructured":"Murphy LL, Munoz RM, Adrian BA, Villanua MA (1998b). Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol Dis 5: 432\u2013446.","journal-title":"Neurobiol Dis"},{"key":"BF1301643_CR57","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1037\/0033-2909.108.3.383","volume":"108","author":"DB Newlin","year":"1990","unstructured":"Newlin DB, Thomson JB (1990). Alcohol challenge with sons of alcoholics: a critical review and analysis. Psychol Bull 108: 383\u2013402.","journal-title":"Psychol Bull"},{"key":"BF1301643_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1210\/er.2005-0009","volume":"27","author":"U Pagotto","year":"2006","unstructured":"Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R (2006). The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27: 73\u2013100.","journal-title":"Endocr Rev"},{"key":"BF1301643_CR59","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1111\/j.1476-5381.1993.tb13989.x","volume":"110","author":"RG Pertwee","year":"1993","unstructured":"Pertwee RG, Stevenson LA, Griffin G (1993). Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. [erratum appears in Br J Pharmacol 1994 Mar; 111(3):968]. Br J Pharmacol 110: 1483\u20131490.","journal-title":"Br J Pharmacol"},{"key":"BF1301643_CR60","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1176\/ajp.149.11.1534","volume":"149","author":"VE Pollock","year":"1992","unstructured":"Pollock VE (1992). Meta-analysis of subjective sensitivity to alcohol in sons of alcoholics. Am J Psychiatry 149: 1534\u20131538.","journal-title":"Am J Psychiatry"},{"key":"BF1301643_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0091-3057(92)90526-L","volume":"42","author":"F Rodriguez De Fonseca","year":"1992","unstructured":"Rodriguez De Fonseca F, Fernandez-Ruiz JJ, Murphy LL, Cebeira M, Steger RW, Bartke A et al (1992). Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas. Pharmacol, Biochem Behav 42: 269\u2013275.","journal-title":"Pharmacol, Biochem Behav"},{"key":"BF1301643_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0091-3057(94)90108-2","volume":"47","author":"F Rodriguez de Fonseca","year":"1994","unstructured":"Rodriguez de Fonseca F, Gorriti MA, Fernandez-Ruiz JJ, Palomo T, Ramos JA (1994). Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav 47: 33\u201340.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301643_CR63","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/(SICI)1098-2396(199811)30:3<298::AID-SYN7>3.0.CO;2-6","volume":"30","author":"J Romero","year":"1998","unstructured":"Romero J, Berrendero F, Manzanares J, Perez A, Corchero J, Fuentes JA et al (1998). Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol. Synapse 30: 298\u2013308.","journal-title":"Synapse"},{"key":"BF1301643_CR64","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/0091-3057(95)00023-P","volume":"51","author":"J Romero","year":"1995","unstructured":"Romero J, Garcia L, Fernandez-Ruiz JJ, Cebeira M, Ramos JA (1995). Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Pharmacol Biochem Behav 51: 731\u2013737.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301643_CR65","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1046\/j.1471-4159.2000.0752080.x","volume":"75","author":"T Rubino","year":"2000","unstructured":"Rubino T, Vigano D, Massi P, Parolaro D (2000a). Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940. J Neurochem 75: 2080\u20132086.","journal-title":"J Neurochem"},{"key":"BF1301643_CR66","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0028-3908(99)00196-3","volume":"39","author":"T Rubino","year":"2000","unstructured":"Rubino T, Vigano D, Massi P, Spinello M, Zagato E, Giagnoni G et al (2000b). Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions. Neuropharmacology 39: 1331\u20131336.","journal-title":"Neuropharmacology"},{"key":"BF1301643_CR67","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0006-8993(96)00941-9","volume":"44","author":"T Rubino","year":"1997","unstructured":"Rubino T, Patrini G, Parenti M, Massi P, Parolaro D (1997). Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system. Brain Res Mol Brain Res 44: 191\u2013197.","journal-title":"Brain Res Mol Brain Res"},{"key":"BF1301643_CR68","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00213-002-1348-z","volume":"165","author":"EB Russo","year":"2003","unstructured":"Russo EB, McPartland JM (2003). Cannabis is more than simply delta(9)-tetrahydrocannabinol. [comment]. Psychopharmacology 165: 431\u2013432; author reply 433\u2013434.","journal-title":"Psychopharmacology"},{"key":"BF1301643_CR69","unstructured":"SAMHSA (2004). Results from the 2003 national survey on drug use and health: national findings. Substance Abuse and Mental Health Services Administration: Rockville, MD."},{"key":"BF1301643_CR70","doi-asserted-by":"publisher","first-page":"180","DOI":"10.15288\/jsa.1991.52.180","volume":"52","author":"MA Schuckit","year":"1991","unstructured":"Schuckit MA, Greenblatt D, Gold E, Irwin M (1991b). Reactions to ethanol and diazepam in healthy young men. J Stud Alcohol 52: 180\u2013187.","journal-title":"J Stud Alcohol"},{"key":"BF1301643_CR71","doi-asserted-by":"publisher","first-page":"368","DOI":"10.15288\/jsa.1996.57.368","volume":"57","author":"MA Schuckit","year":"1996","unstructured":"Schuckit MA, Tsuang JW, Anthenelli RM, Tipp JE, Nurnberger Jr JI (1996). Alcohol challenges in young men from alcoholic pedigrees and control families: a report from the COGA project. J Stud Alcohol 57: 368\u2013377.","journal-title":"J Stud Alcohol"},{"key":"BF1301643_CR72","doi-asserted-by":"publisher","first-page":"601","DOI":"10.15288\/jsa.1991.52.601","volume":"52","author":"MA Schuckit","year":"1991","unstructured":"Schuckit MA, Duthie LA, Mahler HI, Irwin M, Monteiro MG (1991a). Subjective feelings and changes in body sway following diazepam in sons of alcoholics and control subjects. J Stud Alcohol 52: 601\u2013608.","journal-title":"J Stud Alcohol"},{"key":"BF1301643_CR73","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/01.ALC.0000148111.43332.A5","volume":"28","author":"MA Schuckit","year":"2004","unstructured":"Schuckit MA, Smith TL, Anderson KG, Brown SA (2004). Testing the level of response to alcohol: social information processing model of alcoholism risk--a 20-year prospective study. Alcohol Clin Exp Res 28: 1881\u20131889.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF1301643_CR74","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4615-7715-7_2","volume":"3","author":"MA Schuckit","year":"1985","unstructured":"Schuckit MA (1985a). Behavioral effects of alcohol in sons of alcoholics. Recent Dev Alcohol 3: 11\u201319.","journal-title":"Recent Dev Alcohol"},{"key":"BF1301643_CR75","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/archpsyc.1985.01790270065007","volume":"42","author":"MA Schuckit","year":"1985","unstructured":"Schuckit MA (1985c). Ethanol-induced changes in body sway in men at high alcoholism risk. Arch Gen Psychiatry 42: 375\u2013379.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1301643_CR76","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/10550490050173172","volume":"9","author":"MA Schuckit","year":"2000","unstructured":"Schuckit MA (2000). Genetics of the risk for alcoholism. Am J Addict 9: 103\u2013112.","journal-title":"Am J Addict"},{"key":"BF1301643_CR77","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1176\/ajp.151.2.184","volume":"151","author":"MA Schuckit","year":"1994","unstructured":"Schuckit MA (1994). Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 151: 184\u2013189.","journal-title":"Am J Psychiatry"},{"key":"BF1301643_CR78","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/archpsyc.1985.01790340021003","volume":"42","author":"MA Schuckit","year":"1985","unstructured":"Schuckit MA (1985b). The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry 42: 1043\u20131049.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1301643_CR79","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1124\/jpet.102.035618","volume":"303","author":"LJ Sim-Selley","year":"2002","unstructured":"Sim-Selley LJ, Martin BR (2002). Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. J Pharmacol Exp Ther 303: 36\u201344.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1301643_CR80","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1124\/mol.105.019612","volume":"70","author":"LJ Sim-Selley","year":"2006","unstructured":"Sim-Selley LJ, Schechter NS, Rorrer WK, Dalton GD, Hernandez J, Martin BR . et al (2006). Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration. Mol Pharmacol 70: 986\u2013996.","journal-title":"Mol Pharmacol"},{"key":"BF1301643_CR81","unstructured":"Slosson RL (1963). Slosson Intelligence Test (SIT) for Children and Adults. In: Slosson Educational Publications: East Aurora, NY."},{"key":"BF1301643_CR82","volume-title":"Measuring Alcohol Consumption","author":"LC Sobell","year":"1992","unstructured":"Sobell LC, Sobell MB (1992). Timeline follow-back: a technique for assessing self-reported alcohol consumption. Litten AR, Totowa J (eds). Measuring Alcohol Consumption. The Humana Press: NJ, USA."},{"key":"BF1301643_CR83","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511526824","volume-title":"Cannabis and Cognitive Functioning","author":"N Solowij","year":"1998","unstructured":"Solowij N (1998). Cannabis and Cognitive Functioning. Cambridge University Press: Cambridge."},{"key":"BF1301643_CR84","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/0024-3205(95)00197-E","volume":"56","author":"N Solowij","year":"1995","unstructured":"Solowij N (1995). Do cognitive impairments recover following cessation of cannabis use? Life Sci 56: 2119\u20132126.","journal-title":"Life Sci"},{"key":"BF1301643_CR85","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1017\/S0033291706008361","volume":"36","author":"FS Stinson","year":"2006","unstructured":"Stinson FS, Ruan WJ, Pickering R, Grant BF (2006). Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med 36: 1447\u20131460.","journal-title":"Psychol Med"},{"key":"BF1301643_CR86","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1017\/S1121189X0000333X","volume":"13","author":"H Verdoux","year":"2004","unstructured":"Verdoux H, Tournier M (2004). Cannabis use and risk of psychosis: an etiological link? Epidemiologia e Psichiatria Sociale 13: 113\u2013119.","journal-title":"Epidemiologia e Psichiatria Sociale"},{"key":"BF1301643_CR87","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00213-002-1033-2","volume":"161","author":"SR Wachtel","year":"2002","unstructured":"Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H (2002). Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl) 161: 331\u2013339.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1301643_CR88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.31887\/DCNS.2005.7.1\/mweiser","volume":"7","author":"M Weiser","year":"2005","unstructured":"Weiser M, Noy S (2005). Interpreting the association between cannabis use and increased risk for schizophrenia. Dialogues Clin Neurosci 7: 81\u201385.","journal-title":"Dialogues Clin Neurosci"},{"key":"BF1301643_CR89","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0376-8716(03)00135-2","volume":"71","author":"CT Whitlow","year":"2003","unstructured":"Whitlow CT, Freedland CS, Porrino LJ (2003). Functional consequences of the repeated administration of Delta9-tetrahydrocannabinol in the rat. Drug Alcohol Depend 71: 169\u2013177.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301643_CR90","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF00432554","volume":"76","author":"AW Zuardi","year":"1982","unstructured":"Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982). Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology 76: 245\u2013250.","journal-title":"Psychopharmacology"},{"key":"BF1301643_CR91","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF02244189","volume":"104","author":"AW Zuardi","year":"1991","unstructured":"Zuardi AW, Rodrigues JA, Cunha JM (1991). Effects of cannabidiol in animal models predictive of antipsychotic activity. Psychopharmacology 104: 260\u2013264.","journal-title":"Psychopharmacology"},{"key":"BF1301643_CR92","first-page":"485","volume":"56","author":"AW Zuardi","year":"1995","unstructured":"Zuardi AW, Morais SL, Guimaraes FS, Mechoulam R (1995). Antipsychotic effect of cannabidiol [letter]. J Clin Psychiatry 56: 485\u2013486.","journal-title":"J Clin Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1301643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301643","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T04:03:04Z","timestamp":1708488184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1301643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,9]]},"references-count":92,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["BF1301643"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1301643","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,9]]}}}